Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

CHARTWELL RX

  • FDA Approval
  • Oct. 14, 2024, 08:44 UTC
  • 29
  • 0 comments

FDA approve METHYLPREDNISOLONE

Comment Full text

UMEDICA

  • FDA Approval
  • Oct. 14, 2024, 08:44 UTC
  • 34
  • 0 comments

FDA approve EFINACONAZOLE

Comment Full text

AUROBINDO PHARMA USA

  • FDA Approval
  • Oct. 14, 2024, 08:44 UTC
  • 36
  • 0 comments

FDA approve HYDROXYCHLOROQUINE SULFATE

Comment Full text

ANI PHARMS

  • FDA Approval
  • Oct. 14, 2024, 08:44 UTC
  • 35
  • 0 comments

FDA approve ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE

Comment Full text

SANDOZ

  • FDA Approval
  • Oct. 14, 2024, 08:44 UTC
  • 34
  • 0 comments

FDA approve ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE

Comment Full text

CSPC OUYI

  • FDA Approval
  • Oct. 14, 2024, 08:44 UTC
  • 39
  • 0 comments

FDA approve GABAPENTIN

Comment Full text

NORVIUM BIOSCIENCE

  • FDA Approval
  • Oct. 14, 2024, 08:44 UTC
  • 29
  • 0 comments

FDA approve DIVALPROEX SODIUM

Comment Full text

ACCORD BIOPHARMA INC.

  • FDA Approval
  • Oct. 11, 2024, 18:48 UTC
  • 36
  • 0 comments

FDA approve USTEKINUMAB-SRLF

Comment Full text

GENENTECH INC

  • FDA Approval
  • Oct. 11, 2024, 12:15 UTC
  • 36
  • 0 comments

FDA approve INAVOLISIB

Comment Full text

ABBVIE

  • FDA Approval
  • Oct. 11, 2024, 08:41 UTC
  • 38
  • 0 comments

FDA approve BIMATOPROST

Comment Full text
  • Previous
  • 288
  • 289
  • 290
  • 291
  • 292
  • Next

Search

News categories

  • Technical Exchange News(10600)
  • Event(2021)
  • SEC News(184886)
  • FDA Approval(9847)
  • Company Report(721)
  • Business News(122482)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin